Response to Comment on "An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia"

Pharmacoeconomics. 2022 Dec;40(12):1265-1267. doi: 10.1007/s40273-022-01213-y. Epub 2022 Nov 11.

Authors

Marjanne A Piena¹, Natalie Houwing², Carla W Kraan², Xiaofeng Wang³, Heidi Waters³, Craig Bennison⁴

Affiliations

¹ OPEN Health, Rotterdam, The Netherlands. MarjannePiena@openhealthgroup.com.
² OPEN Health, Rotterdam, The Netherlands.
³ Otsuka Pharmaceutical Companies, Princeton, NJ, USA.
⁴ OPEN Health, York, UK.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adult
Economics, Pharmaceutical*
Health Services
Humans
Research Design
Schizophrenia* / drug therapy